Ten Bokkel Huinink S, Biemans V, Duijvestein M, Pierik M, et al. Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease. Eur J Gastroenterol Hepatol 2021;33.
PMID: 34334713